QUALITY OF LIFE AND ABILITY TO WORK OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH THYROSINE KINASE INHIBITORS
EHA Library, S.M.Amine BENLAZAR, 181248
QUALITY OF LIFE AND EMPLOYMENT AFTER AN HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A MEXICAN POPULATION.
EHA Library, Silvia Rivas-Vera, 181249
ANTHRACYCLINE INCREASES THE RISK OF DEVELOPING DIABETES IN B CELL LYMPHOMA
EHA Library, Chieh-Lin Teng, 181250
COST-EFFECTIVENESS OF LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN CHINA
EHA Library, Jin Lu, 181251
DEVELOPMENT OF A NEW HAEMATOLOGICAL MALIGNANT PATIENT-REPORTED OUTCOME MEASURE FOR USE IN CLINICAL PRACTICE: HM-PRO
EHA Library, Pushpendra Goswami, 181252
OVARIAN TISSUE CRYOPRESERVATION IN PEDIATRIC AND ADOLESCENT PATIENTS UNDERGOING CANCER CHEMOTHERAPY AND/OR HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Akitoshi Kinoshita, 181253
A MULTI-DISCIPLINARY APPROACH TO CHEMOTHERAPY PRESCRIBING AT NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST
EHA Library, Sumantha Gabriel, 181254
FINANCIAL TOXICITY OF THE MANAGEMENT OF MULTIPLE MYELOMA
EHA Library, S.M.Amine BENLAZAR, 181255
THE IMPLICATIONS OF NON-PROPORTIONAL HAZARDS FOR THE MEASUREMENT OF SURVIVAL BENEFIT IN HEALTH TECHNOLOGY ASSESSMENT: CURRENT APPROACHES AND THE ROLE OF RESTRICTED MEAN SURVIVAL TIME
EHA Library, Giles Monnickendam, 181256
DISEASE SEVERITY AND SLOWER PSYCHOMOTOR SPEED IN ADULTS WITH SICKLE CELL DISEASE
EHA Library, Enrico Novelli, 181257
MONITORING OF CHRONIC HEPATIC DAMAGE IN SICKLE CELL DISEASE: LONGITUDINAL OBSERVATION OF A COHORT OF ADULT PATIENTS
EHA Library, Gian Luca Forni, 181258
MICROSTRUCTURAL ANALYSIS OF RETINO-CHOROID LAYERS USING OPTICAL COHERENCE TOMOGRAPHY IN ADULT PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Giovanna Graziadei, 181259
NON‐ABLATIVE TRANSPLANT CONDITIONING WITH TREOSULFAN IS CURATIVE IN A MURINE MODEL OF SICKLE CELL DISEASE
EHA Library, Divya Devadasan, 181260
SILENT CEREBRAL ISCHEMIA AND THROMBOEMBOLIC EVENTS IN SICKLE CELL DISEASE: ANALYSIS OF COAGULATION PARAMETERS AND THROMBOELASTOGRAPHY
EHA Library, Maria Dimopoulou, 181261
INVASIVE BACTERIAL INFECTIONS IN GAMBIAN PATIENTS WITH SICKLE CELL ANEMIA IN AN ERA OF WIDESPREAD PNEUMOCOCCAL AND HAEMOPHILUS INFLUENZA TYPE B VACCINATION
EHA Library, Germander Soothill, 181263
THE ASSOCIATION OF IGF-1 AND IGFBP-3 SERUM LEVELS AND GENE EXPRESSION WITH THE PATHOGENESIS OF INFLAMMATION IN SICKLE CELL DISEASE
EHA Library, S Ünal, 181264
UNIVERSAL NEWBORN SCREENING FOR SICKLE CELL DISEASE: PRELIMINARY RESULTS OF THE FIRST YEAR OF A MULTICENTRIC ITALIAN PILOT PROJECT
EHA Library, R Colombatti, 181265
EXTENDING ACCESS TO CARE FOR CHILDREN WITH SICKLE CELL DISEASE THROUGH TELEHEALTH
EHA Library, Julie Kanter, 181266
EMERGING NEED FOR SICKLE CELL DISEASE NEWBORN SCREENING PROGRAM IN ITALY, A EUROPEAN COUNTRY WITH INTENSE MIGRATION FLUXES
EHA Library, Donatella Venturelli, 181267
GENETIC HEMOLYTIC MARKER IN SICKLE CELL ANAEMIA
EHA Library, Patricia Nascimento, 181268
ASSESSMENT OF INTERNATIONAL DAY HOSPITALS/INFUSION UNITS FOR THE EVALUATION AND TREATMENT OF SICKLE CELL DISEASE
EHA Library, Laura De Castro, 181269
REDUCED SERUM HAEMOPEXIN LEVELS IN HAEMOGLOBIN SC DISEASE OCCUR INDEPENDENTLY FROM THE DEGREE OF HAEMOLYSIS
EHA Library, Felipe Vendrame, 181270
ASSOCIATION OF TOLL-LIKE RECEPTOR 2 GENE POLYMORPHISM WITH THE INCIDENCE OF BACTERIAL INFECTIONS IN SICKLE CELL DISEASE.
EHA Library, Karina Tozatto Maio, 181271
HIGH PROGNOSTIC VALUE OF PRE-SCT MOLECULAR MINIMAL RESIDUAL DISEASE ASSESSMENT BY WT1 GENE EXPRESSION IN AML TRANSPLANTED IN CYTOLOGIC COMPLETE REMISSION.
EHA Library, Anna CANDONI, 181272
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER ΑLFA-BETA TCR/CD19+ DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT).
EHA Library, Lucia PREZIOSO, 181273
UNMANIPULATED HAPLOIDENTICAL TRANSPLANTATION CONDITIONING WITH BUSULFAN, CYCLOPHOSPHAMIDE AND ANTI-THYMOGLOBULIN FOR ADULT SEVERE APLASTIC ANEMIA: GOOD OUTCOME AND PROGNOSIS ANALYSIS
EHA Library, Zhengli Xu, 181274
PLERIXAFOR EFFICIENTLY AND SAFELY MOBILIZES PERIPHERAL BLOOD STEM CELLS: HOVON-107 RESULTS IN HLA-IDENTICAL SIBLING DONORS AND TRANSPLANTED RECIPIENTS.
EHA Library, G.E. De Greef, 181275
A FEASIBILITY STUDY OF THE FULL OUTPATIENT CONDUCT OF HEMATOPOIETIC TRANSPLANTS IN PERSONS WITH MULTIPLE SCLEROSIS EMPLOYING AUTOLOGOUS NON-CRYOPRESERVED PERIPHERAL BLOOD STEM CELLS
EHA Library, Guillermo Jose Ruiz Argüelles, 181276
VEDOLIZUMAB IN STEROID REFRACTORY INTESTINAL GRAFT-VERSUS-HOST DISEASE
EHA Library, Anders Myhre, 181277
RISK FACTORS, OUTCOMES AND CHARACTERIZATION OF ‘AUTOLOGOUS GRAFT VERSUS HOST DISEASE’: THE MAYO CLINIC EXPERIENCE.
EHA Library, Theodora Anagnostou, 181278
CNS DEMYELINATION AFTER HAPLO-HSCT AND ITS ASSOCIATION WITH THE IGG INTRATHECAL SYNTHESIS INDEX AND ANTI-MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY IN CEREBROSPINAL FLUID
EHA Library, Xiaohui Zhang, 181279
BASELINE CREATININE CLEARANCE AND ALBUMIN ARE POWERFUL RISK FACTORS FOR ALLOGENEIC TRANSPLANTATION RELATED MORTALITY
EHA Library, Roni Shouval, 181280
CYTOGENETIC AND MOLECULAR RISK FACTORS AT DIAGNOSIS ARE OVERCOME BY WT1 AND FLOW CYTOMETRY-BASED PRE TRANSPLANT MINIMAL RESIDUAL DISEASE ASSESSMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
EHA Library, Fabio Guolo, 181281
IMPACT OF ALLELE SPECIFIC PATIENT:DONOR HLA DISPARITY ON OUTCOME OF REDUCED INTENSITY TRANSPLANTS PERFORMED USING HLA MISMATCHED UNRELATED DONORS: ON BEHALF OF THE ALWP OF THE EBMT
EHA Library, Charles Craddock, 181282
PRE-EMPTIVE THERAPY WITH IFN-Α-2B FOR ACUTE LEUKEMIA PATIENTS WITH HIGH RISK OF RELAPSING TENDENCY POST ALLO-HSCT
EHA Library, Xiaowen Tang, 181283
PREDICTING SURVIVAL AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION. THE GATMO SCORE
EHA Library, Mariano Berro, 181284
A RETROSPECTIVE ANALYSIS OF PATIENT CHARACTERISTICS AND RISK FACTORS FOR ADMISSION TO THE INTENSIVE CARE UNIT (ICU) FOLLOWING HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT (HDC-ASCT)
EHA Library, Logeswari Jeyaraj Nallathambi, 181285
AUTOLOGOUS STEM CELL TRANSPLANTATION WITH BENDA-EAM (BENDAMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN) IN AGGRESSIVE NON HODGKIN AND HODGKIN´S LYMPHOMA
EHA Library, Ralph Simanek, 181286
THROMBOTIC MICROANGIOPATHY WITH CONCOMITANT AGVHD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: RISK FACTORS, SEVERE OUTCOME AND TREATMENT EXPERIENCE
EHA Library, Xiaohui Zhang, 181287
SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE MONITORING BY QUANTITATIVE RT-PCR IN CORE BINDING FACTOR AML ON TRANSPLANTATION OUTCOMES
EHA Library, Betul Oran, 181288
LONG-TERM OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION IN ADULT SEVERE APLASTIC ANEMIA WITH ABNORMAL CYTOGENETICS AT DIAGNOSIS
EHA Library, Sung-Eun Lee, 181289
PROGNOSTIC VALUE OF PET/CT PRIOR TO AUTOLOGOUS HCT IN RELAPSED / REFRACTORY LYMPHOMA
EHA Library, Moussab Damlaj, 181290
COMPARISON OF OUTCOMES AFTER DONOR LYMPHOCYTE INFUSION WITH OR WITHOUT PRIOR CHEMOTHERAPY FOR MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.
EHA Library, Xiao-Dong Mo, 181291
DIFFERENTIAL PROGNOSTIC IMPACT OF HEMATOPOIETIC CELL TRANSPLANTATION SPECIFIC COMORBIDITY INDEX (HCT-CI) ON TRANSPLANT OUTCOMES BY STEM CELL SOURCES
EHA Library, Yoshitaka Adachi, 181292
LOW DOSE POSTTRANSPLANTATION CYCLOPHOSPHAMIDE CAN ENHANCE THE PROTECTIVE EFFECT OF ATG /G-CSF ON GVHD: RESULTS OF A PHASE II PROSPECTIVE TRIAL
EHA Library, Yu Wang, 181293
HEPATITIS B REACTIVATION IN HEMATOPOIETIC STEM CELL TRANSPLANTED PATIENTS: 22 YEARS EXPERIENCE OF A SINGLE CENTRE
EHA Library, Teoman Soysal, 181294
ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FROM HAPLOIDENTICAL DONOR WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE WAS RELATED TO LESS INPATIENT COST COMPARED TO CORD BLOOD TRANSPLANTATION
EHA Library, Naoki Kurita, 181295
THE ROLE OF PPARΓ EXPRESSION IN PATIENTS WITH AGVHD FOLLOWING ALLO-HSCT
EHA Library, Depei Wu, 181296
HAPLOIDENTICAL TRANSPLANTATION WITH MYELOABLATIVE CONDITIONING REGIMEN COULD SERVE AS AN OPTIONAL SALVAGE THERAPY FOR YOUNGER PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKIN LYMPHOMA
EHA Library, Haiwen Huang, 181297
OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA HARBORING INV(3)/(Q21;Q26.2)/T(3;3)(Q21;Q26.2)
EHA Library, Jun Aoki, 181298
PHARMACOKINETICS (PK) OF PROPYLENE GLYCOL-FREE MELPHALAN HCL (PG-FREE MEL) IN MULTIPLE MYELOMA (MM) PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION (AHCT)
EHA Library, PARAMESWARAN HARI, 181299
IMPAIRED LYMPHOCYTE RECONSTITUTION AFTER AUTOLOGOUS TRANSPLANT IS ASSOCIATED WITH APOPTOSIS OF CD8+ T CELLS AND PREDICTS ADVERSE CLINICAL OUTCOME
EHA Library, Uri ROZOVSKI, 181300
COMPARISON OF TECAM AND BEAM HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LYMPHOMA: EFFICACY AND TOXICITY
EHA Library, Fahri Sahin, 181301
GENETIC MARKERS OF THE NEUTROPENIA DURATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Elena Nazarova, 181302
SUCCESSFUL TREATMENT WITH GRANULOCYTE TRANSFUSION AND EARLY NEUTROPHIL ENGRAFTMENT IN ALLOGENEIC TRANSPLANT PATIENTS WITH FEBRILE NEUTROPENIA;
EHA Library, Ali Unal, 181303
DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE
EHA Library, Bulent Antmen, 181304
ACUTE RENAL IMPAIRMENT IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS, A PREDICTOR OF MORTALITY
EHA Library, Ali Mahdi, 181305
PREDICTIVE INDEXES FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, A SINGLE-CENTER EXPERIENCE
EHA Library, Joud , 181306
ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGH-RISK PERIPHERAL T-CELL LYMPHOMAS
EHA Library, Haiwen Huang, 181307
IMPACT OF BASELINE BILIRUBIN ON SURVIVAL IN PATIENTS WITH HEPATIC VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME RECEIVING DEFIBROTIDE: POST-HOC ANALYSIS OF EXPANDED-ACCESS PROTOCOL FINAL DATA
EHA Library, PAUL RICHARDSON, 181308
LONG-TERM FOLLOW-UP OF A PROSPECTIVE TRIAL OF INTENSIFIED CHEMO-IMMUNOTHERAPY WITH AUTOLOGOUS OR ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS AFFECTED BY PERIPHERAL T-CELL LYMPHOMA
EHA Library, Paolo Corradini, 181309
UNRELATED DONOR ATTRITION AT A LATE STAGE: THE BRITISH BONE MARROW REGISTRY EXPERIENCE
EHA Library, Katalin Balassa, 181310
POLIMORPHISM IN TGFB1 GENE PREDISPOSES TO RELAPSE AND DEVELOPMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE GRADES III-IV.
EHA Library, Nora Meggyesi, 181311
EARLY AND LATE LOST OF PROTECTIVE ANTIBODY LEVELS AGAINST MEASLES, MUMPS AND RUBELLA IN PATIENTS GIVEN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
EHA Library, Jan Bögeholz, 181312
MICA AND NKG2D POLYMORPHISMS HAVE A SIGNIFICANT IMPACT ON GRAFT VERSUS HOST DISEASE AFTER HLA-MATCHED HEMATOPOÏETIC STEM CELL TRANSPLANTATION.
EHA Library, Marie-Joelle Apithy, 181313
STEM CELL TRANSPLANTATION WITH MYELOABLATIVE CONDITIONING USING TIMED SEQUENTIAL BUSULFAN IMPROVES OUTCOMES IN OLDER AML AND MDS PATIENTS
EHA Library, Betul Oran, 181314
HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH DEPLETION OF TCR ΑΒ (+) IN CHILDREN: ERCIYES PEDIATRIC BMT CENTER
EHA Library, Turkan Patıroglu, 181315
SECONDARY MYELODYSPLASTIC SYNDROME AND/OR ACUTE LEUKEMIA INCIDENCE AFTER AUTOLOGOUS TRANSPLANTATION FOR LYMPHOMA PATIENTS IS CONNECTED WITH DECREASE OF HEMATOPOIETIC RESERVE.
EHA Library, Marek Trneny, 181316
USE OF DEFIBROTIDE TO TREAT TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY
EHA Library, María Esther Martínez-Muñoz, 181317
PRE-TRANSPLANT COMORBIDITY AS AN OUTCOME PREDICTOR IN HEMATOPOIETIC CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA
EHA Library, Sungnam Lim, 181318
EFFICACY AND SAFETY OF FILGRASTIM BIOSIMILAR COMPARED TO FILGRASTIM ORIGINATOR IN THE STEM CELL MOBILIZATION AND HEMATOPOIETIC ENGRAFTMENT IN PATIENTS UNDERGOING STEM CELL TRANSPLANTATION
EHA Library, Miriam López-Parra, 181319
PERIPHERAL BLOOD STEM CELL DONATION IN OLDER SIBLING DONORS: IS IT SAFE?
EHA Library, Katalin Balassa, 181320
LONG-TERM RESULTS OF DONOR LYMPHOCYTE INFUSIONS IN RELAPSED AND MIXED CHIMERISM PATIENTS AFTER ALLOGENEIC STEM CELLS TRANSPLANTATION.
EHA Library, Olga Koroleva, 181321
MEMORY T CELLS DONOR LYMPHOCYTE INFUSIONS AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION AS A SAFE PROCEDURE TO IMPROVE T-CELL RECONSTITUTION
EHA Library, Susan Cortez Clemente, 181322
FLAG REGIMEN WITH IDARUBICINE AS CYTOREDUCTION THERAPY BEFORE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH REFRACTORY ACUTE MYELOID LEUKEMIA
EHA Library, Ling WANG, 181323
STUTTER PCR PRODUCTS MAY NOT INTERFERE WITH STR BASED CHIMERISM MONITORING AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
EHA Library, Natalia Kostritsa, 181324
INTRODUCING PLERIXAFOR TO IMPROVE MOBILIZATION IN MULTIPLE MYELOMA PATIENTS WHO BEHAVE AS POOR-MOBILIZERS IS COST-EFFECTIVE CONSIDERING THE WHOLE MOBILIZATION AND TRANSPLANT PROCEDURE
EHA Library, Christian Chabannon, 181325
PERIPHERAL BLOOD STEM CELL (PBSC) HAPLOIDENTICAL TRANSPLANTATION VERSUS MISMATCHED UNRELATED DONOR TRANSPLANTATION: A SINGLE UK CENTRE EXPERIENCE
EHA Library, Jennifer O'SULLIVAN, 181326
IMPACT OF ABO BLOOD GROUP INCOMPATIBILITY ON THE OUTCOME OF RECIPIENTS UNDERGOING ALLOGENIC TRASPLANTATION: EXPERIENCE IN OUR CENTER BETWEEN 2013 AND 2016.
EHA Library, Gala Aglaia Méndez Navarro, 181327
THE EXPRESSION OF TOLL-LIKE RECEPTORS GENES IN PATIENTS WITH LYMPHOID MALIGNANCIES AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.
EHA Library, Justyna Rybka, 181329
TIMING OF DEFIBROTIDE INITIATION POST-DIAGNOSIS OF HEPATIC VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: EXPANDED ACCESS PROGRAM FINAL DATA
EHA Library, PAUL RICHARDSON, 181330
RED BLOOD CELL DISTRIBUTION WIDTH (RDW) AS AN ACUTE GRAFT VERSUS HOST DISEASE PREDICTOR MARKER IN ALLOGENIC STEM CELL TRANSPLANTATION.
EHA Library, Bernardo Lopez Andrade, 181331
COMPARISON OF THE BEEAM CONDITIONING REGIMEN AND THE BEAM CONDITIONING REGIMEN IN THE AUTOLOGOUS TRANSPLANATAION FOR HL AND NHL.
EHA Library, Stefan Lozenov, 181332
DOUBLE UMBILICAL CORD BLOOD TRANSPLANTATION IN ADULTS: CORRELATION OF ALLELE-LEVEL HLA MATCHING WITH OUTCOME AND WHICH CORD BLOOD UNIT WILL BECOME DOMINANT
EHA Library, Mara Westendorp, 181333
CLINICAL ANALYSIS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR 46 ACTIVE RELAPSED AND REFRACTORY ACUTE PEDIATRIC LEUKEMIA
EHA Library, Jingbo Wang, 181334
POST-TRANSPLANT HIGH-DOSE CYCLOPHOSPHAMIDE AFFECT T-CELL RECONSTITUTION IN BONE MARROW, BUT NOT IN PERIPHERAL BLOOD STEM CELLS RECIPIENTS
EHA Library, Ekaterina Mikhaltsova, 181335
OUTCOMES OF PATIENTS RELAPSING FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION FOR AML IN FIRST CR: SINGLE CENTER EXPERIENCE
EHA Library, Domenico Pastore, 181336
ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH CHEMOREFRACTORY HODGKIN LYMPHOMAS: A RETROSPECTIVE MULTICENTER EXPERIENCE OF THE RETE EMATOLOGICA PUGLIESE (REP).
EHA Library, Vincenzo Pavone, 181337
RESULTS OF THE IMPLEMENTATION OF CRYOTHERAPY IN PROTOCOLS OF ORAL MUCOSITIS PROPHYLAXIS IN PATIENTS SUBJECT TO A TRASPLANT OF HEMATOPOYETIC PROGENITORS. EXPERIENCE OF ONE CENTER.
EHA Library, Elena Fernández Poveda, 181338
REDUCED INCIDENCE OF PRIMARY GRAFT FAILURE IN PATIENTS UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE.
EHA Library, Angélica Martínez, 181339
RESULTS OF HAPLOIDENTIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA: A SINGLE CENTER EXPERIENCE
EHA Library, zafer gulbas, 181340
COLLECTION OF PERIPHERAL BLOOD HEMATOPOIETIC PROGENITOR CELLS (PBPC) FROM HEALTHY DONORS: 15 YEARS SINGLE CENTER EXPERIENCE.
EHA Library, Beatriz Aguado Bueno, 181341
ALLORESPONSES OF HUMAN T-CELLS FROM ADULT PERIPHERAL BLOOD AND UMBILICAL CORD BLOOD ARE DIFFERENTIALLY IMPACTED BY LENALIDOMIDE - IMPLICATIONS FOR AHSCT
EHA Library, Caroline Besley, 181342
USING MARKER GENES ANALYSIS INSTEAD OF MLR ASSAY FOR IDENTIFICATION OF FUNCTIONAL CD4+FOXP3+ REGULATORY T CELLS IN GVHD PROPHYLAXIS
EHA Library, Tzeon-Jye Chiou, 181343
OXIDANT-ANTIOXIDANT SYSTEM IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Lusine Aleksanian, 181344
SURFACE RECEPTOR EXPRESSION PROFILE DEFINES ALLOREACTIVE DONOR CD8+ T-CELLS AFTER MURINE ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION
EHA Library, Musga Qureischi, 181345
SOLUBLE FORM OF TRANSFERRIN RECEPTOR IS ASSOCIATED WITH AGE AT DIAGNOSIS AND RISK OF THERAPEUTICAL INTERVENTION AND IRON OVERLOAD IN PATIENTS WITH NON-TRANSFUSION- DEPENDENT THALASSAEMIA.
EHA Library, Antonella Meloni, 181346
LOW SERUM FERRITIN LEVELS DO NOT PROTECT FROM CARDIAC AND HEPATIC IRON IN PATIENTS WITH THALASSEMIA MAJOR
EHA Library, Antonella Meloni, 181347
ISCHEMIA MODIFIED ALBUMIN AS A MARKER OF OXIDATIVE STRESS IN CHILDREN AND ADOLESCENTS WITH Β-THALASSEMIA: RELATION TO LIPID PEROXIDATION, IRON OVERLOAD AND VASCULAR DYSFUNCTION
EHA Library, Amira Abdel Moneam, 181348
PRENATAL DIAGNOSIS OF HEMOGLOBINOPATHIES IN NORTHERN GREECE. 15 YEARS REPORT
EHA Library, Stamatia Theodoridou, 181350

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings